ε€ͺε‡―ε€šηŽ‹ε­
02-18

$Tempus AI(TEM)$  🚨 Tempus AI (TEM) – Overhyped or the Next Big Thing? 🚨

πŸ”₯ Tempus AI is soaring at $91 (highest point), but is the hype justified? Here’s the REAL breakdown:

πŸ“‰ Fundamentals Say SELL

πŸ”Ή P/S Ratio: 20.6x (Industry Avg: 8x)

πŸ”Ή EV/Revenue: 27.5x (More than double high-growth AI stocks)

πŸ”Ή Massive overvaluation compared to Palantir, Datadog & Recursion Pharma

πŸ“Š Fair Value Estimate: $32

Based on Q2 & Q3 2024 reports, the stock should trade between $20-$48 – meaning a 63% downside risk from current levels!

πŸš€ Hype or Reality?

Yes, AI & Healthcare Data is the future, but can Tempus AI justify this valuation? If growth slows, a major correction is coming.

πŸ’‘ What’s your take? Is TEM a Buy, Hold, or Sell? Drop your thoughts below! ⬇️ 

AI+Health: Can TEM Earnings Support High Estimates?
AI healthcare stocks have been hitting new highs recently. After Pelosi increased her holdings in TEM, it has surged 100%. RXRX jumped nearly 50% following NVIDIA's disclosure, while HIMS has also gained over 50% this month. JPMorgan stated at the Healthcare Conference that AI's role in drug development is becoming increasingly important. TEM will release earnings next week. ---------------- Do you believe in the potential of AI healthcare stocks? Can TEM earnings support the high estimates?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1